Delivery Order SPE2DB22D1017-SPE2DB25FF2SZ

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,562.38 firm fixed-price delivery order contract is for the provision of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $21,772.04, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENBREL 50 MG/ML syringes and is a Firm Fixed Price Delivery Order with a performance period ending on January 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,591.28 Firm Fixed Price Delivery Order covers the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication, with a completion date of December 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,765.38 firm fixed-price contract is for the supply of 4,566,279,993 ENBREL 25 MG/0.5 ML syringes, with an ultimate completion date of October 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $83,224.67 Firm Fixed Price delivery order contract is for the provision of ENBREL 50 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,983.69 Firm Fixed Price Delivery Order is for the supply of Enbrel, a 50 mg/mL injectable medication, with a completion date of February 9, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $80,069.90 Firm Fixed Price Delivery Order contract is for the supply of ENBREL 50 MG/ML SURECLICK, a specialty medication. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,691.18 firm fixed-price delivery order is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $11,537.80 firm-fixed price Delivery Order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of ENBREL 50 MG/ML syringes and has a completion date of September 5, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of essential medical commodities to various federal agencies, including the military. This contract award is part of AmerisourceBergen's...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of ENBREL 50 MG/ML SYRINGEML. The $9,197.29 firm fixed-price delivery order contract has a completion date of January 13, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF2SZ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,158.68 Firm Fixed Price Delivery Order is for the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award was not designated with a set-aside requirement, indicating open competition.

Generated 4/13/25, 12:58 AM